EUDA on Nasdaq
EUDA Health Holdings Ltd
EUDA Health Holdings Ltd is a health services company that raised $940,000 in 2023 (SEC Form D).1
Price unavailable
Last updated Oct 20, 2026.
Overview
Compare with VSEE HEALTH, INC., Longduoduo Co Ltd or Agape ATP Corp, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Property Management Service Common Area Management brought in 48% of the revenue EUDA Health Holdings Ltd broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Property Management Service Common Area Management | $2.6M | $2.9M | $3.3M |
| Wellness Therapies Service | $75.6K | $1.8M | |
| Property Management Service Security Management | $1.1M | $1.1M | $1.1M |
| Holistic Wellness Consumer Products | $3.3K | $406.6K | |
| Stem Cell Treatment Service | $217.0K | ||
| Licensing Service of Bio Energy Cabin | $7.3K | $53.3K | |
| Wellness Membership Program | $2.9K | $3.1K |
Regions
SGMember brought in 71% of the revenue EUDA Health Holdings Ltd broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| SGMember | $3.7M | $3.9M | $4.8M |
| MYMember | $89.0K | $2.0M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue56¢$3.8M
- Research and development0¢$249
- Other costs43¢$3.0M
- Income tax1¢$41.9K
Out of $6.8M in revenue.2 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenues | $6.8M | $4.0M | $3.7M |
| Total Cost of Revenues | $3.8M | $3.2M | $2.9M |
| GROSS PROFIT | $3.0M | $762.2K | $842.1K |
| Selling | $1.3M | $129.9K | $533.6K |
| General and administrative | $4.1M | $3.2M | $4.3M |
| Impairment loss of long-lived assets | $37.5K | $14.8M | |
| Research and development | $249 | ||
| Total Operating Expenses | $5.5M | $18.1M | $4.8M |
| LOSS FROM OPERATIONS | -$2.5M | -$17.3M | -$4.0M |
| Interest expense, net | -$228.6K | -$44.9K | -$23.2K |
| Change in fair value of prepaid forward purchase liabilities | -$1.3M | ||
| Change in fair value of warrant liabilities | -$25.0K | ||
| Loss on settlement of prepaid forward contracts | -$2.6M | ||
| Loss on debt settlement | -$448.0K | -$645.6K | |
| Other income, net | $5.8K | $185.9K | $134.6K |
| Total Other Expense, net | -$247.8K | -$307.0K | -$4.5M |
| LOSS BEFORE INCOME TAXES | -$2.7M | -$17.6M | -$8.4M |
| INCOME TAXES EXPENSE (BENEFITS) | $41.9K | -$4.4K | |
| NET LOSS FROM CONTINUING OPERATIONS | -$2.8M | -$17.6M | -$8.4M |
| NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS, net of income taxes | $2.2M | -$1.6M | |
| NET LOSS | -$2.8M | -$15.4M | -$10.0M |
| Less: Net income (loss) attributable to noncontrolling interest from continuing operations | $5.1K | -$34.3K | $3.4K |
| NET LOSS ATTRIBUTABLE TO EUDA HEALTH HOLDINGS LIMITED | -$2.8M | -$15.4M | -$10.0M |
| FOREIGN CURRENCY TRANSLATION ADJUSTMENT | $49.9K | -$75.4K | -$60.0K |
| TOTAL COMPREHENSIVE LOSS | -$2.7M | -$15.5M | -$10.1M |
| Less: Comprehensive income (loss) attributable to noncontrolling interest | $6.4K | -$35.6K | $3.1K |
| COMPREHENSIVE LOSS ATTRIBUTABLE TO EUDA HEALTH HOLDINGS LIMITED | -$2.7M | -$15.4M | -$10.1M |
| Basic | 1.9M shares | 1.6M shares | 1.1M shares |
| Diluted | 1.9M shares | 1.6M shares | 1.1M shares |
| Basic - continuing operations | -$1 | -$11 | -$7 |
| Diluted - continuing operations | -$1 | -$11 | -$7 |
| Basic - discontinued operations | $1 | -$1 | |
| Diluted - discontinued operations | $1 | -$1 | |
| Basic | -$1.48 | -$9.46 | -$8.77 |
| Diluted | -$1.48 | -$9.46 | -$8.77 |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash | $345.1K | $237.6K | ||
| Accounts receivable, net | $242.6K | $146.2K | ||
| Inventories, net | $2.8K | $129.0K | ||
| Prepaid expenses and other current assets | $357.2K | $226.0K | ||
| Total Current Assets | $1.0M | $762.9K | ||
| PROPERTY AND EQUIPMENT, NET | $137.3K | $87.7K | ||
| Prepaid expenses - non-current | $183.5K | $281.4K | ||
| Intangible assets, net | $161.4K | $337.3K | ||
| Operating lease right-of-use assets | $177.0K | $203.0K | ||
| Finance lease right-of-use assets | $18.0K | $25.6K | ||
| Total Other Assets | $539.9K | $847.2K | ||
| Total Assets | $1.7M | $1.7M | ||
| Accounts payable | $14.1K | $25.9K | ||
| Other payables and accrued liabilities | $2.0M | $1.6M | ||
| Customer deposits | $522.0K | $477.9K | ||
| Warrants liabilities | $125.0K | |||
| Operating lease liabilities | $127.0K | $174.8K | ||
| Finance lease liabilities | $6.3K | $4.6K | ||
| Taxes payable | $85.5K | $263.0K | ||
| Total Current Liabilities | $5.8M | $4.1M | ||
| Deferred tax liabilities | $81.1K | $76.7K | ||
| Operating lease liabilities - non-current | $50.1K | $28.2K | ||
| Finance lease liabilities - non-current | $17.4K | $23.6K | ||
| Total Other Liabilities | $148.6K | $128.5K | ||
| Total Liabilities | $6.0M | $4.3M | ||
| Ordinary shares, no par value, unlimited shares authorized, 1,890,375 shares and 1,857,653 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $48.8M | $47.8M | ||
| Accumulated deficit | -$52.9M | -$50.1M | ||
| Accumulated other comprehensive loss | -$211.0K | -$259.5K | ||
| Total Euda Health Holdings Limited Shareholders Deficit | -$4.3M | -$2.6M | ||
| Noncontrolling interests | -$12.6K | -$19.0K | ||
| Total Shareholders Deficit | -$4.3M | -$2.6M | -$7.5M | -$3.5M |
| Total Liabilities and Shareholders Deficit | $1.7M | $1.7M | ||
| Common stock, par value | $0.00 | $0.00 | ||
| Common stock, shares outstanding | 1.9M shares | 1.9M shares | ||
| Common stock, shares issued | 1.9M shares | 1.9M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash | $345.1K | $237.6K | ||
| Accounts receivable, net | $242.6K | $146.2K | ||
| Inventories, net | $2.8K | $129.0K | ||
| Prepaid expenses and other current assets | $357.2K | $226.0K | ||
| Total Current Assets | $1.0M | $762.9K | ||
| PROPERTY AND EQUIPMENT, NET | $137.3K | $87.7K | ||
| Prepaid expenses - non-current | $183.5K | $281.4K | ||
| Intangible assets, net | $161.4K | $337.3K | ||
| Operating lease right-of-use assets | $177.0K | $203.0K | ||
| Finance lease right-of-use assets | $18.0K | $25.6K | ||
| Total Other Assets | $539.9K | $847.2K | ||
| Total Assets | $1.7M | $1.7M | ||
| Accounts payable | $14.1K | $25.9K | ||
| Other payables and accrued liabilities | $2.0M | $1.6M | ||
| Customer deposits | $522.0K | $477.9K | ||
| Warrants liabilities | $125.0K | |||
| Operating lease liabilities | $127.0K | $174.8K | ||
| Finance lease liabilities | $6.3K | $4.6K | ||
| Taxes payable | $85.5K | $263.0K | ||
| Total Current Liabilities | $5.8M | $4.1M | ||
| Deferred tax liabilities | $81.1K | $76.7K | ||
| Operating lease liabilities - non-current | $50.1K | $28.2K | ||
| Finance lease liabilities - non-current | $17.4K | $23.6K | ||
| Total Other Liabilities | $148.6K | $128.5K | ||
| Total Liabilities | $6.0M | $4.3M | ||
| Ordinary shares, no par value, unlimited shares authorized, 1,890,375 shares and 1,857,653 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $48.8M | $47.8M | ||
| Accumulated deficit | -$52.9M | -$50.1M | ||
| Accumulated other comprehensive loss | -$211.0K | -$259.5K | ||
| Total Euda Health Holdings Limited Shareholders Deficit | -$4.3M | -$2.6M | ||
| Noncontrolling interests | -$12.6K | -$19.0K | ||
| Total Shareholders Deficit | -$4.3M | -$2.6M | -$7.5M | -$3.5M |
| Total Liabilities and Shareholders Deficit | $1.7M | $1.7M | ||
| Common stock, par value | $0.00 | $0.00 | ||
| Common stock, shares outstanding | 1.9M shares | 1.9M shares | ||
| Common stock, shares issued | 1.9M shares | 1.9M shares |
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| NET LOSS | -$2.8M | -$15.4M | -$10.0M |
| Net income (loss) from discontinued operations | $2.2M | -$1.6M | |
| Net loss from continuing operations | -$2.8M | -$17.6M | -$8.4M |
| Depreciation | $38.5K | $22.1K | $4.9K |
| Amortization of intangible assets | $156.7K | $20.2K | |
| Amortization of operating right-of-use asset | $202.2K | $125.5K | $106.3K |
| Amortization of finance right-of-use assets | $9.1K | $5.5K | $8.1K |
| Provision for credit losses | $44.9K | $2.5K | |
| Inventory write-down | $86.7K | ||
| Deferred taxes benefits | $4.4K | -$4.4K | |
| Gain on termination of finance lease | -$7.2K | ||
| Loss on disposal of intangible assets | $11.2K | ||
| Impairment loss on long-lived assets | $37.5K | $14.8M | |
| Change in fair value of prepaid forward purchase liabilities | $1.3M | ||
| Change in fair value of warrants liabilities | $25.0K | ||
| Loss on settlement of prepaid forward contracts | $2.6M | ||
| Loss on debt settlement | $448.0K | $645.6K | |
| Gain from forgiveness on promissory note | -$10.0K | ||
| Accounts receivable | -$86.0K | $85.2K | -$34.0K |
| Other receivables | -$81.0K | $210 | $1.0K |
| Other receivables, related parties | -$3.1K | ||
| Inventories, net | $45.4K | -$126.3K | |
| Prepaid expenses and other current assets | -$22.2K | $69.3K | $61.6K |
| Accounts payable | -$12.9K | $16.0K | $1.3K |
| Other payables and accrued liabilities | $344.5K | -$235.2K | $519.7K |
| Customer deposits | -$24.6K | $451.3K | |
| Taxes payable | -$191.0K | $62.9K | $87.9K |
| Operating lease liability | -$202.2K | -$125.5K | -$106.3K |
| Net cash used in operating activities from continuing operations | -$2.4M | -$2.0M | -$3.2M |
| Net cash used in operating activities from discontinued operations | -$9.2K | $296.0K | |
| Net cash used in operating activities | -$2.4M | -$2.0M | -$2.9M |
| Purchases of equipment | -$77.3K | -$96.8K | |
| Purchases of intangible assets | -$27.2K | -$19.3K | |
| Cash acquired through assets acquisition | $16.3K | ||
| Loan to third parties | -$44.9K | ||
| Net cash used in investing activities from continuing operations | -$104.5K | -$144.6K | |
| Net cash used in investing activities from discontinued operations | -$3.1K | ||
| Net cash used in investing activities | -$104.5K | -$147.8K | |
| Proceeds from issuance of warrants | $100.0K | ||
| Proceeds received from convertible notes | $1.0M | $1.5M | |
| Repayments of convertible note | -$300.0K | ||
| Proceeds received from Issuance of ordinary shares through private placements | $50.0K | $790.0K | |
| Proceeds from short-term loans - private lenders | $471.4K | $784.3K | |
| Repayments to short-term loans - private lenders | -$595.3K | -$256.9K | |
| Proceeds received from short-term loans - related parties | $1.3M | $436.2K | $1.2M |
| Repayments to short-term loans - related parties | $208.9K | ||
| Advance from other payables - related parties | $234.5K | -$140.9K | |
| Payment of finance lease liabilities | -$6.2K | -$4.5K | -$5.9K |
| Repayments to discontinued operations entities | $493.8K | ||
| Net cash provided by financing activities from continuing operations | $2.6M | $2.1M | $2.7M |
| Net cash provided by financing activities from discontinued operations | $256.1K | -$371.9K | |
| Net cash provided by financing activities | $2.6M | $2.3M | $2.4M |
| EFFECT OF EXCHANGE RATE CHANGES | $88.5K | -$101.7K | -$21.5K |
| NET CHANGE IN CASH | $107.5K | $40.1K | -$586.9K |
| Cash paid for income tax | $32.2K | $11.6K | $42.9K |
| Cash paid for interest | $6.0K | $55.4K | $17.5K |
| Initial recognition of operating right-of-use assets and lease liabilities | $256.2K | $159.4K | $236.7K |
| Initial recognition of financing right-of-use assets and lease liabilities | $36.2K | ||
| Derecognition of financing right-of-use assets upon lease termination | $80.9K | $12.9K | |
| Derecognition of financing lease liabilities upon lease termination | $19.3K | ||
| Issuance of ordinary shares upon conversion of convertible notes | $1.0M | $3.6M | $1.4M |
| Issuance of ordinary shares upon settlement of debts | $1.7M | $1.5M | |
| Issuance of ordinary shares upon settlement of prepaid forward contracts | $2.4M | ||
| Reclassification of other payables and accrued liabilities upon settlement of a promissory note | $160.0K | ||
| Issuance of ordinary shares in assets acquisition | $15.0M | ||
| Issuance of convertible notes in settlement of short-term loans related parties, and other payables - related party | $935.4K |
No quarter-by-quarter statement was filed.
Corporate structure
EUDA Health Holdings Ltd sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of EUDA Health Holdings Ltd
- Meng Dong Tan Filed SCHEDULE 13G/A on EUDA Health Holdings Ltd, latest Jun 8, 2026 (5 filings since Feb 14, 2022)
- Xin (nmn) Zhang Filed SCHEDULE 13G on EUDA Health Holdings Ltd, latest Jun 5, 2026
- Ayrton Capital LLC Filed SC 13G/A on EUDA Health Holdings Ltd, latest Feb 14, 2023 (2 filings since Nov 23, 2022)
- Hudson Bay Capital Management LP Filed SC 13G/A on EUDA Health Holdings Ltd, latest Feb 7, 2023 (2 filings since Feb 2, 2022)
- Karpus Management, Inc. Filed SC 13G/A on EUDA Health Holdings Ltd, latest Dec 9, 2022 (2 filings since Feb 14, 2022)
- Watermark Developments Ltd Filed SC 13D on EUDA Health Holdings Ltd, latest Nov 25, 2022
- Lawrence Feis Filed SC 13G/A on EUDA Health Holdings Ltd, latest Mar 24, 2022 (3 filings since Nov 30, 2021)
- Weiss Asset Management LP Filed SC 13G on EUDA Health Holdings Ltd, latest Feb 11, 2022
- Space Summit Capital LLC Filed SC 13G/A on EUDA Health Holdings Ltd, latest Feb 2, 2022 (2 filings since Nov 30, 2021)
- 8i Holdings 2 Pte Ltd Filed SC 13G on EUDA Health Holdings Ltd, latest Dec 2, 2021
- Saba Capital Management, L.P. Filed SC 13G on EUDA Health Holdings Ltd, latest Dec 2, 2021
- EUDA Health Holdings Ltd D8
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What EUDA Health Holdings Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $247.9K2 Dec 31, 2025 | $178.6K2 Dec 31, 2024 | +38.8% |
| Accumulated depreciation | $110.6K2 Dec 31, 2025 | $90.8K2 Dec 31, 2024 | +21.7% |
| Property and equipment, net | $137.3K2 Dec 31, 2025 | $87.7K2 Dec 31, 2024 | +56.5% |
| Finance-lease assets | $18.0K2 Dec 31, 2025 | $25.6K2 Dec 31, 2024 | −29.7% |
| Operating-lease assets (leased space) | $177.0K2 Dec 31, 2025 | $203.0K2 Dec 31, 2024 | −12.8% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $05 Dec 31, 2024 | $05 Dec 31, 2023 | |
| Intangible assets, net (excluding goodwill) | $161.4K2 Dec 31, 2025 | $337.3K2 Dec 31, 2024 | −52.1% |
| Finite-lived intangibles, gross | $331.0K2 Dec 31, 2025 | $357.5K2 Dec 31, 2024 | −7.4% |
| Accumulated amortization | $169.6K2 Dec 31, 2025 | $20.2K2 Dec 31, 2024 | +738.8% |
| Finite-lived intangibles, net | $161.4K2 Dec 31, 2025 | $337.3K2 Dec 31, 2024 | −52.1% |
Inventory
Leadership
Who has led EUDA Health Holdings Ltd, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerMeng Dong Tan Nov 22, 2021 to Nov 24, 20219
- Chief financial officerWhye Shin Tay Mar 18, 2026 to now10
- Chief financial officerSteven John Sobak Nov 25, 2022 to Nov 25, 202211
- Chief financial officerGuan Hong William Yap Nov 22, 2021 to Nov 22, 202112
Board members and other officers (11)
- Board memberChern Yong Lew Mar 18, 2026 to now13
- Board memberKongyew Wong Jun 8, 2023 to Jun 8, 202314
- Board memberAlfred Lim Nov 25, 2022 to Nov 25, 202215
- Board memberDavid Francis Capes Nov 25, 2022 to Nov 25, 202216
- Board memberKim Hing Chan Nov 25, 2022 to Nov 25, 202217
- Board memberThien Su Gerald Lim Nov 25, 2022 to Nov 25, 202218
- Board memberAjay Raipal Nov 22, 2021 to May 23, 202319
- Board memberAlexander K. Arrow Nov 22, 2021 to Nov 22, 202120
- Board memberGuan Hong William Yap Nov 22, 2021 to Nov 22, 202112
- Board memberKwong Yeow Liew Nov 22, 2021 to now21
- Board memberMeng Dong Tan Nov 22, 2021 to Nov 24, 20219
Named in SEC Form D filings
People the company listed in its private-offering notices.
Former names
- 8i Acquisition 2 Corp.Apr 19, 2021 to Nov 17, 20223
Timeline
- Jun 15, 20238-K Listing notice or transfer; Other events23
- Jun 9, 20238-K Entered a material agreement; Ended a material agreement; Unregistered sale of shares24
- May 26, 20238-K Entered a material agreement; Unregistered sale of shares25
- May 24, 20238-K Executive or director change26
- May 19, 20238-K Executive or director change; Other events27
- May 19, 20238-K Listing notice or transfer28
- May 11, 20238-K Executive or director change29
- Apr 10, 20238-K Listing notice or transfer30
- Mar 15, 20238-K Executive or director change31
- Mar 7, 20238-K Executive or director change32
- Mar 1, 20238-K Other events33
- Feb 17, 20238-K Executive or director change34
- Nov 22, 2021New chief executive Meng Dong Tan becomes CEO9
Filings
224 filings to the SEC since October 2021: 7 annual reports, 5 quarterly reports, 28 major events, 27 insider forms, 22 large holders, 1 private raises, 134 other. The latest 20:
- Oct 13, 20266-K EDGAR
- Oct 13, 20266-K EDGAR
- Sep 29, 20266-K EDGAR
- Aug 26, 20266-K EDGAR
- Aug 11, 2026424B3 EDGAR
- Aug 10, 2026EFFECT EDGAR
- Jul 31, 2026F-3/A EDGAR
- Jul 31, 20266-K EDGAR
- Jul 28, 20266-K EDGAR
- Jul 22, 2026424B5 EDGAR
- Jul 17, 2026F-3/A EDGAR
- Jul 7, 2026F-3/A EDGAR
- Jun 11, 2026424B5 EDGAR
- Jun 10, 20266-K EDGAR
- Jun 8, 2026SCHEDULE 13G/A EDGAR
- Jun 5, 2026SCHEDULE 13G EDGAR
- Jun 1, 20266-K EDGAR
- Jun 1, 20266-K EDGAR
- May 26, 2026F-3 EDGAR
- Apr 28, 20266-K EDGAR
The 224 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
1 open-market trades by officers, directors and large owners since October 2021: 1 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 24, 2021 | Tan Meng Dong (James)10% owner | Buy | 292,250 | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Meng Dong TanSCHEDULE 13G/A, 5 filings Feb 14, 2022 to Jun 8, 202635
- Xin (nmn) ZhangSCHEDULE 13G, 1 filing Jun 5, 202636
- Ayrton Capital LLCSC 13G/A, 2 filings Nov 23, 2022 to Feb 14, 202337
- Hudson Bay Capital Management LPSC 13G/A, 2 filings Feb 2, 2022 to Feb 7, 202338
- Karpus Management, Inc.SC 13G/A, 2 filings Feb 14, 2022 to Dec 9, 202239
- Watermark Developments LtdSC 13D, 1 filing Nov 25, 202240
- Lawrence FeisSC 13G/A, 3 filings Nov 30, 2021 to Mar 24, 202241
- Weiss Asset Management LPSC 13G, 1 filing Feb 11, 202242
- Space Summit Capital LLCSC 13G/A, 2 filings Nov 30, 2021 to Feb 2, 202243
- 8i Holdings 2 Pte LtdSC 13G, 1 filing Dec 2, 202144
- Saba Capital Management, L.P.SC 13G, 1 filing Dec 2, 202145
Money raised
Private offerings the company reported to the SEC on Form D.
- May 16, 2023Raised $940,000 in a private offering of equity Form D: $4 million offered in all Form D
SEC filer profile
How EUDA Health Holdings Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGAREUDA Health Holdings Ltd1
- CIK0001847846
- Filer statusNon-accelerated filer an emerging growth company; a shell company46
- Incorporated inBritish Virgin Islands46
- Fiscal year endsDecember 311
- Industry code (SIC)8000 Services-Health Services1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address60 Kaki Bukit Place, #03-01, Eunos Techpark, 415979, Singapore1
- Phone65 678803881
- Shares outstanding1,890,375 shares as of Dec 31, 202546
- AuditorJ&S Associate PLT, Kuala Lumpur, Malaysia PCAOB ID 6743; no auditor attestation of internal control over financial reporting46
- On EDGAR sinceApr 19, 20211
- Filings246 in all: 6-K (63), 8-K (28), CORRESP (21), 3 (19), UPLOAD (16), SC 13G (11), 424B5 (10), DEFA14A (9)1
All 39 form types
4 (8), SC 13G/A (6), 10-Q (5), S-1/A (5), EFFECT (4), F-3/A (4), 20-F (3), PRER14A (3), 10-K (2), 20-F/A (2), 25-NSE (2), 424B3 (2), F-1/A (2), F-3 (2), S-1 (2), SC 13D (2), 424B4 (1), 425 (1), 6-K/A (1), 8-A12B (1), CERT (1), D (1), DEFM14A (1), DRS (1), NT 10-K (1), NT 10-Q (1), NT 20-F (1), PREM14A (1), SC 13D/A (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)
- Latest filingsAnnual report (20-F) Apr 28, 2026
Quarterly report (10-Q) Jul 31, 2023
Latest 8-K (8-K) Jun 15, 2023
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Ordinary Shares | EUDA | The Nasdaq Stock Market LLC |
| Redeemable Warrants | EUDAW | The Nasdaq Stock Market LLC |
From the cover page of the 20-F filed Apr 28, 2026 (Section 12(b) of the Exchange Act).46
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARChern Yong Lew, Board member
- 14SEC EDGARKongyew Wong, Board member
- 15SEC EDGARAlfred Lim, Board member
- 16SEC EDGARDavid Francis Capes, Board member
- 17SEC EDGARKim Hing Chan, Board member
- 18SEC EDGARThien Su Gerald Lim, Board member
- 19SEC EDGARAjay Raipal, Board member
- 20SEC EDGARAlexander K. Arrow, Board member
- 21SEC EDGARKwong Yeow Liew, Board member
- 22
- 23
- 24
- 25
- 26SEC EDGARExecutive or director change
- 27
- 28SEC EDGARListing notice or transfer
- 29SEC EDGARExecutive or director change
- 30SEC EDGARListing notice or transfer
- 31SEC EDGARExecutive or director change
- 32SEC EDGARExecutive or director change
- 33SEC EDGAROther events
- 34SEC EDGARExecutive or director change
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46